Share

The notion that humanity's most daunting challenges are insurmountable is being systematically dismantled by a new breed of companies. According to Bob Mumgaard, CEO of the fusion energy venture Commonwealth Fusion Systems (CFS), we are living in a unique historical window where the technological capability to solve problems once relegated to science fiction finally exists. In a recent discussion, Mumgaard pointed to the trajectories of Tesla, SpaceX, and Moderna as definitive proof that game-changing, society-altering breakthroughs are not only possible but are happening now. This perspective, shared by influential backers of CFS like former Google CEO Eric Schmidt, Salesforce co-founder Mark Benioff, and venture capitalist Vinod Khosla, suggests a fundamental shift in what is considered achievable in business and technology. (Updated: May 23, 2024)
The success stories of Tesla and SpaceX are particularly instructive. Both companies were initially met with profound skepticism from established industry players and analysts. Electric vehicles were seen as niche, impractical, and inferior to internal combustion engines, while reusable rockets were considered a financial and engineering fantasy. Through relentless iteration, vertical integration, and a willingness to challenge every conventional assumption, these companies didn't just enter their respective markets—they completely redefined them. Tesla catalyzed the entire global auto industry's pivot to electrification, and SpaceX drastically reduced the cost of access to space, enabling new satellite constellations and renewed ambitions for lunar and Martian exploration. Their journeys demonstrate that "impossible" is often a function of outdated mental models and risk aversion, not physical law.
Moderna's story adds a critical, and more recent, dimension to this thesis. Prior to the COVID-19 pandemic, mRNA technology was a promising but unproven platform for vaccines. The unprecedented global crisis compressed a decade of development and regulatory process into less than a year. Moderna, leveraging its foundational research, demonstrated that with sufficient urgency, focus, and resource alignment, a completely novel medical technology could be developed, tested, and deployed at a global scale with stunning efficacy. This achievement showed that the "impossible" timeline is another barrier that can be shattered, reinforcing the idea that the tools for radical innovation are not just physical but also organizational and regulatory.
Bob Mumgaard's Commonwealth Fusion Systems is itself a direct bet on this philosophy. The quest for commercial fusion energy has been the archetypal "always 30 years away" problem for decades. CFS, spun out of MIT, is employing high-temperature superconducting magnets to build smaller, more efficient fusion devices, notably its SPARC prototype. The company's progress, including a landmark demonstration of its magnet technology in 2021, has attracted over $2 billion in investment. Mumgaard's argument is that the confluence of advanced materials science, high-performance computing for simulation, and increased private capital willing to take on grand challenges has created the necessary "toolkit" to finally tackle fusion. The backing from Schmidt, Benioff, and Khosla—investors who have witnessed and fueled other paradigm shifts—lends significant credibility to this claim.
This evolving landscape offers a crucial insight for entrepreneurs and investors: the frontier of the possible is expanding. The playbook is no longer limited to incremental software improvements or consumer apps. There is a growing appetite and a demonstrable capacity to attack fundamental problems in physics, biology, transportation, and energy. The common thread among Tesla, SpaceX, and Moderna is their foundational ambition—they aimed to change the underlying rules of a system, not just to capture a slightly larger market share within the existing paradigm.
The implications extend beyond venture capital and into public policy and corporate strategy. Governments and large corporations are now observing that moonshot projects can be executed effectively by focused, mission-driven entities, sometimes faster than by large bureaucratic organizations. This is fostering new public-private partnership models and encouraging incumbent firms to establish their own ambitious "skunkworks" divisions to avoid disruption. The success of these companies serves as a compelling case study in setting audacious goals, attracting top talent motivated by purpose, and managing the long-term technical and financial risk that such endeavors inherently carry.
Looking ahead, the domains ripe for similar "impossible" solutions are becoming clearer. Next-generation battery chemistry for grid-scale storage, low-cost carbon capture systems, novel agricultural techniques to combat food insecurity, and next-generation computing architectures are all areas where the confluence of need, enabling technology, and investment is reaching a critical point. The lesson from the current pioneers is not that success is guaranteed, but that the barriers are now more often economic and executional rather than purely scientific. The tools, as Mumgaard asserts, are indeed here. The remaining variable is the human will and ingenuity to apply them to the world's most pressing challenges.









